2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

講師

Kerry Blanchard


Session 1 – A Fascinating Year of Biotech Innovation and Investment
Date: 24 July (Wednesday)  14:00 - 16:30
Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom A
 


 

Kerry Blanchard

Chief Science Officer
Innovent Biologics

Dr. Blanchard is responsible for drug discovery, translational medicine , medical science, medical writing , clinical pharmacology , scientific disclosure, statistics and registration application at Innovent. He received a BS in chemistry, a Ph.D. in biochemistry, and a MD from Indiana University. He completed a residency in Internal Medicine and fellowships in Hematology and Medical Oncology at the Brigham and Women’s Hospital, the Dana Farber Cancer Center, and Harvard Medical School. Previously, Dr. Blanchard acted as Senior Vice President in China MDU and External Innovation of Lilly China and has more than 18 years of leading drug discovery and drug development experience.